Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading stock research

Loading market dashboard

My Watchlist

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

Living Cell Technologies Limited

LVCLY

HealthcareOTCAU

$0.0306

+$0.006 (+24.39%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

LVCLY

1Y0 (0.00%)

Candles, volume, SMA 20, and SMA 50

O 0.0306H 0.0306L 0.0306C 0.0306Date Jul 11

LVCLY

SMA 20 SMA 50 Vol 0EEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$11.39M

Volume?244

Avg Volume?908

52w Range$0.02 - $0.08

Beta?0.76

Price Performance

0.0%

$0.0306 to $0.0306

YTD

0.0%